Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with Cis-platinum, vinblastine and bleomycin: A long-term follow-up
- 1 April 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (4), 733-736
- https://doi.org/10.1016/0277-5379(89)90211-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Bleomycin Causes Alveolar Macrophages from Cigarette Smokers to Release Hydrogen PeroxideThe American Journal of the Medical Sciences, 1988
- Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinomaCancer Chemotherapy and Pharmacology, 1985
- Pulmonary toxicity of antitumor agentsCancer Treatment Reviews, 1983
- Role of pulmonary function tests in the prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratomaEuropean Journal of Cancer and Clinical Oncology, 1982
- COMBINATION CHEMOTHERAPY WITH CIS-DIAMMINE-DICHLORO-PLATINUM, VINBLASTINE, AND BLEOMYCIN IN ADVANCED TESTICULAR NON-SEMINOMAThe Lancet, 1979
- Factors influencing postoperative morbidity and mortality in patients treated with bleomycin.BMJ, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Ultrastructure of pulmonary bleomycin toxicityCancer, 1973
- Bleomycin, an Antitumor AntibioticAnnals of Internal Medicine, 1972
- A Standardized Breath Holding Technique for the Clinical Measurement of the Diffusing Capacity of the Lung for Carbon Monoxide 1JCI Insight, 1957